vs

Side-by-side financial comparison of FirstCash Holdings, Inc. (FCFS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

FirstCash Holdings, Inc. is the larger business by last-quarter revenue ($501.3M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). FirstCash Holdings, Inc. runs the higher net margin — 20.8% vs 6.8%, a 14.0% gap on every dollar of revenue. On growth, FirstCash Holdings, Inc. posted the faster year-over-year revenue change (21.2% vs -1.7%). Over the past eight quarters, FirstCash Holdings, Inc.'s revenue compounded faster (16.9% CAGR vs -0.1%).

FirstCash Holdings, Inc. is an American pawnshop company headquartered in Fort Worth, Texas which operates retail pawn stores in the U.S. and Latin America. It is a publicly traded company listed on the Nasdaq stock exchange.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

FCFS vs MD — Head-to-Head

Bigger by revenue
FCFS
FCFS
1.0× larger
FCFS
$501.3M
$493.8M
MD
Growing faster (revenue YoY)
FCFS
FCFS
+22.9% gap
FCFS
21.2%
-1.7%
MD
Higher net margin
FCFS
FCFS
14.0% more per $
FCFS
20.8%
6.8%
MD
Faster 2-yr revenue CAGR
FCFS
FCFS
Annualised
FCFS
16.9%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCFS
FCFS
MD
MD
Revenue
$501.3M
$493.8M
Net Profit
$104.2M
$33.7M
Gross Margin
Operating Margin
28.5%
9.9%
Net Margin
20.8%
6.8%
Revenue YoY
21.2%
-1.7%
Net Profit YoY
24.7%
10.5%
EPS (diluted)
$2.35
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCFS
FCFS
MD
MD
Q4 25
$501.3M
$493.8M
Q3 25
$411.0M
$492.9M
Q2 25
$385.1M
$468.8M
Q1 25
$371.1M
$458.4M
Q4 24
$413.7M
$502.4M
Q3 24
$363.1M
$511.2M
Q2 24
$363.5M
$504.3M
Q1 24
$366.8M
$495.1M
Net Profit
FCFS
FCFS
MD
MD
Q4 25
$104.2M
$33.7M
Q3 25
$82.8M
$71.7M
Q2 25
$59.8M
$39.3M
Q1 25
$83.6M
$20.7M
Q4 24
$83.5M
$30.5M
Q3 24
$64.8M
$19.4M
Q2 24
$49.1M
$-153.0M
Q1 24
$61.4M
$4.0M
Operating Margin
FCFS
FCFS
MD
MD
Q4 25
28.5%
9.9%
Q3 25
27.4%
13.8%
Q2 25
21.1%
12.8%
Q1 25
30.0%
7.0%
Q4 24
26.5%
7.8%
Q3 24
23.5%
6.6%
Q2 24
18.2%
-31.3%
Q1 24
22.3%
3.2%
Net Margin
FCFS
FCFS
MD
MD
Q4 25
20.8%
6.8%
Q3 25
20.1%
14.5%
Q2 25
15.5%
8.4%
Q1 25
22.5%
4.5%
Q4 24
20.2%
6.1%
Q3 24
17.9%
3.8%
Q2 24
13.5%
-30.3%
Q1 24
16.7%
0.8%
EPS (diluted)
FCFS
FCFS
MD
MD
Q4 25
$2.35
$0.40
Q3 25
$1.86
$0.84
Q2 25
$1.34
$0.46
Q1 25
$1.87
$0.24
Q4 24
$1.86
$0.37
Q3 24
$1.44
$0.23
Q2 24
$1.08
$-1.84
Q1 24
$1.35
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCFS
FCFS
MD
MD
Cash + ST InvestmentsLiquidity on hand
$125.2M
$375.2M
Total DebtLower is stronger
$2.2B
$570.5M
Stockholders' EquityBook value
$2.3B
$865.9M
Total Assets
$5.3B
$2.2B
Debt / EquityLower = less leverage
0.98×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCFS
FCFS
MD
MD
Q4 25
$125.2M
$375.2M
Q3 25
$130.2M
$340.1M
Q2 25
$101.5M
$224.7M
Q1 25
$146.0M
$99.0M
Q4 24
$175.1M
$229.9M
Q3 24
$106.3M
$103.8M
Q2 24
$113.7M
$19.4M
Q1 24
$135.1M
$8.0M
Total Debt
FCFS
FCFS
MD
MD
Q4 25
$2.2B
$570.5M
Q3 25
$2.2B
$577.2M
Q2 25
$1.7B
$583.9M
Q1 25
$1.7B
$590.5M
Q4 24
$1.7B
$597.1M
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.5B
Stockholders' Equity
FCFS
FCFS
MD
MD
Q4 25
$2.3B
$865.9M
Q3 25
$2.2B
$890.7M
Q2 25
$2.1B
$833.8M
Q1 25
$2.1B
$789.2M
Q4 24
$2.1B
$764.9M
Q3 24
$2.0B
$732.5M
Q2 24
$2.0B
$706.5M
Q1 24
$2.0B
$856.2M
Total Assets
FCFS
FCFS
MD
MD
Q4 25
$5.3B
$2.2B
Q3 25
$5.2B
$2.2B
Q2 25
$4.5B
$2.1B
Q1 25
$4.4B
$2.0B
Q4 24
$4.5B
$2.2B
Q3 24
$4.4B
$2.1B
Q2 24
$4.3B
$2.0B
Q1 24
$4.2B
$2.2B
Debt / Equity
FCFS
FCFS
MD
MD
Q4 25
0.98×
0.66×
Q3 25
1.01×
0.65×
Q2 25
0.79×
0.70×
Q1 25
0.83×
0.75×
Q4 24
0.85×
0.78×
Q3 24
0.87×
Q2 24
0.85×
Q1 24
0.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCFS
FCFS
MD
MD
Operating Cash FlowLast quarter
$206.6M
$114.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.98×
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCFS
FCFS
MD
MD
Q4 25
$206.6M
$114.1M
Q3 25
$135.8M
$137.3M
Q2 25
$116.9M
$137.2M
Q1 25
$126.6M
$-117.5M
Q4 24
$198.1M
$133.0M
Q3 24
$113.1M
$91.8M
Q2 24
$106.2M
$107.0M
Q1 24
$122.5M
$-125.2M
Cash Conversion
FCFS
FCFS
MD
MD
Q4 25
1.98×
3.39×
Q3 25
1.64×
1.91×
Q2 25
1.95×
3.49×
Q1 25
1.51×
-5.66×
Q4 24
2.37×
4.36×
Q3 24
1.74×
4.72×
Q2 24
2.16×
Q1 24
2.00×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FCFS
FCFS

US Pawn Segment$292.2M58%
Retail POS Payment Solutions$209.8M42%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons